Taiwan FDA registration 79cb8c5daaeae76d1b3609d55a40c36c
"Stryker" Target split coil
TW: “史賽克”塔吉特分離線圈
Taiwan·Risk Class 3·Stryker Neurovascular·Registered May 09, 2011 – May 09, 2026ExpiredRegistration details
- Analysis ID
- 79cb8c5daaeae76d1b3609d55a40c36c
- Customs Code
- DHA00602237703
Company information
- Manufacturer
- Stryker Neurovascular
- Manufacturer Country
- Ireland
- Authorized Representative
- STRYKER FAR EAST INC. TAIWAN BRANCH (USA)
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- K Neuroscience
- Product Type (Level 2)
- K.5950 Artificial embolization device
- Import Information
- import
Dates and status
- Registration Date
- May 09, 2011
- Expiry Date
- May 09, 2026
About this record
Access comprehensive regulatory information for "Stryker" Target split coil in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 79cb8c5daaeae76d1b3609d55a40c36c and manufactured by Stryker Neurovascular. The authorized representative in Taiwan is STRYKER FAR EAST INC. TAIWAN BRANCH (USA).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices